Aion Therapeutic Inc. (CSE:AION) confirmed in a statement that it has closed its previously announced non-brokered private placement – issuing 42.75 million stock units comprising one common share and one half share warrant.
The units were sold to investors at 1 cent per unit, raising a total of $427,500 which is earmarked for ‘general working capital purposes’.
Aion Therapeutic describes itself as a forward-thinking business in the health and wellness sector, with a diverse portfolio of intellectual property.